Evidence map›Paper›PMID 40428062›Full record

ArticleBioengineering (Basel, Switzerland)2025

Non-Invasive Localization of Epileptogenic Zone in Drug-Resistant Epilepsy Based on Time-Frequency Analysis and VGG Convolutional Neural Network.

Yaqing Liu, Yalin Wang, Tiancheng Wang

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yaqing LiuThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
Yalin WangSchool of Information Science and Engineering, Lanzhou University, Lanzhou 730000, China.ORCID 0000-0002-4440-7705
Tiancheng WangThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou 730030, China.ORCID 0000-0001-9701-8845

Funding

Natural Science Foundation of Gansu Province 25JRRA721
6 · The paper itself

Abstract

The mainstream method for treating drug-resistant epilepsy (DRE) is surgical resection of the epileptogenic zone. Non-invasive automatic localization of epileptogenic zone can be used to guide electrode implantation and improve the effectiveness and safety of neurosurgical treatments. Previous researchers have proposed a range of methods for this purpose, but these suffer from limits such as unclear post-operative outcomes, invasiveness, limited data volume, and single DRE type. This study constructed a non-invasive epilepsy localization method, integrating sLORETA source imaging, time-frequency analysis, and Visual Geometry Group (VGG-16) deep learning. Firstly, 16-channel scalp electroencephalogram (EEG) from 25 successfully operated DRE patients were included. Secondly, time-frequency features by short-time Fourier transform (STFT), continuous wavelet transform (CWT), and superlets algorithm were extracted. Finally, the VGG-16 network was applied to automatically locate the epileptogenic zone. All three feature extraction methods achieved significant accuracy on the dataset. Using STFT for processing and combining it with VGG-16 for image classification achieved an average classification accuracy of 80.2% and a channel identification rate of 80.7% for epileptogenic zones. After processing with CWT, the accuracy increased to 81.7% and the epileptogenic zone channel recognition rate increased to 81.4%. After processing with the superlets method, the classification accuracy was further improved to 83.1%, and the epileptogenic zone channel recognition rate was increased to 83.3%. This marks the pioneering proposal of a systematic framework for non-invasive localization to the epileptogenic zone.

Indexed as

drug-resistant epilepsyepileptogenic zonenon-invasive localizationtime–frequency analysisVGG-16

Identifiers

PMID40428062
PMCPMC12109204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.